Comminuted form of (s)-2-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) penyl] propanoic acid
Номер патента: MY125099A
Опубликовано: 31-07-2006
Автор(ы): Agneta Hallgren, Kristina Roos
Принадлежит: AstraZeneca AB
Опубликовано: 31-07-2006
Автор(ы): Agneta Hallgren, Kristina Roos
Принадлежит: AstraZeneca AB
Реферат: THE PRESENT INVENTION RELATES TO A REDUCED PARTICLE SIZE FORM OF THE COMPOUND (S)-2-ETHOXY-3-[4-(2-{4-METHANESULFONYLOXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID, AS SHOWN IN FORMULA 1 BELOW, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF OR A SOLVATE OF EITHER THEREOF.THE INVENTION ALSO CONCERNS METHODS OF TREATING ONE OR MORE CONDITIONS ASSOCIATED WITH INSULIN RESISTANCE SYNDROME USING THE REDUCED PARTICLE SIZE FORM OF THE COMPOUND, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN THE MANUFACTURE OF A MEDICAMENT FOR USE IN ONE OR MORE OF SAID CONDITIONS.THE INVENTIONS FURTHER CONCERNS PHARMACEUTICAL COMPOSITONS CONTAINING THE REDUCED PARTICLE SIZE FORM OF THE COMPOUND, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE THEREOF,AS AN ACTIVE INGREDIENT, AS WELL AS PROCESSES FOR THE MANUFACTURE OF THE REDUCED PARTICLE SIZE FORM OF THE COMPOUND, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.
Comminuted form of (s)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
Номер патента: CA2392029A1. Автор: Agneta Hallgren,Kristina Roos. Владелец: Individual. Дата публикации: 2001-06-07.